An excellent example in this direction is membranous nephropathy, where the current Kidney Disease: Improving Global Outcomes guidelines recommend to spare a kidney biopsy if anti-PLA2R autoantibodies are detected, but kidney function is normal.8 This evidence concerns the gene PLA2R1 and membranous glomerulonephritis.